Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Total Liabilities (2018 - 2025)

AVITA Medical's Total Liabilities history spans 8 years, with the latest figure at $73.0 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 2.57% year-over-year to $73.0 million; the TTM value through Dec 2025 reached $73.0 million, down 2.57%, while the annual FY2025 figure was $73.0 million, 2.57% down from the prior year.
  • Total Liabilities reached $73.0 million in Q4 2025 per RCEL's latest filing, up from $70.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $75.0 million in Q4 2024 to a low of $8.7 million in Q1 2022.
  • Average Total Liabilities over 5 years is $37.6 million, with a median of $16.9 million recorded in 2023.
  • Peak YoY movement for Total Liabilities: fell 5.12% in 2022, then skyrocketed 377.3% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $11.4 million in 2021, then grew by 13.84% to $13.0 million in 2022, then surged by 377.3% to $61.9 million in 2023, then rose by 21.13% to $75.0 million in 2024, then fell by 2.57% to $73.0 million in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Total Liabilities are $73.0 million (Q4 2025), $70.4 million (Q3 2025), and $71.0 million (Q2 2025).